J&J | JNJ - Umsatzkosten

Aktienkurs
241.13
Täglich Wechseln
-0.17 -0.07%
Monatlich
-1.06%
Jährlich
62.17%
Q2 Prognose
235.72




Umsatzkosten Veränderung Datum
AbbVie USD 4.55B 757M 2025-12
Abbott USD 4.92B 535M 2025-12
Amgen USD 1.79B 128M 2025-12
AstraZeneca USD 3.27B 471M 2025-12
Baxter International USD 2.4B 512M 2025-12
Bayer EUR 4.5B 194M 2025-12
Becton, Dickinson and Co. USD 2.84B 2.35B 2025-12
Biogen USD 810.1M 205.1M 2025-09
Boston Scientific USD 1.84B 82M 2025-12
Bristol-Myers Squibb USD 4.92B 657M 2025-12
CONMED USD 154.91M 16.9M 2025-12
Cooper Companies USD 376.8M 87.4M 2025-12
Dexcom USD 466.9M 11M 2025-12
Edwards Lifesciences USD 343M 2.2M 2025-12
Eli Lilly USD 3.37B 363.7M 2025-12
Gilead Sciences USD 1.62B 50M 2025-12
GlaxoSmithKline GBP 2.61B 377M 2025-12
Globus Medical USD 290.47M 8.09M 2025-12
Hologic USD 463.7M 5.1M 2025-12
Insulet USD 215.2M 19M 2025-12
Integra LifeSciences USD 193.44M 1.62M 2025-12
Intuitive Surgical USD 961.9M 119.2M 2025-12
J&J USD 7.97B 689M 2025-12
Medtronic USD 3.61B 83M 2025-12
Merck USD 3.32B 531M 2025-12
Merit Medical Systems USD 198.58M 838K 2025-12
Novartis USD 3.54B 3M 2025-12
Pfizer USD 6.29B 2.12B 2025-12
Regeneron Pharmaceuticals USD 584.6M 63M 2025-12
Roche Holding CHF 8.48B 4.61B 2025-12
Sanofi EUR 4.29B 421M 2025-12
Stryker USD 2.69B 373M 2025-12
Tandem Diabetes Care USD 122.92M 7.96M 2025-12
Teva Pharmaceutical Industries USD 2.06B 120M 2025-12
Vertex Pharmaceuticals USD 466M 51.2M 2025-12
Zimmer Biomet Holdings USD 970.1M 234.3M 2025-12
Zoetis USD 743M 60M 2025-12